T 0888/24 of 14.04.2026
- European Case Law Identifier
- ECLI:EP:BA:2026:T088824.20260414
- Date of decision
- 14 April 2026
- Case number
- T 0888/24
- Online on
- 18 May 2026
- Petition for review of
- -
- Application number
- 17186150.3
- IPC class
- C07D 413/14A61P 7/00A61K 31/422
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- CRYSTALLINE FORM K OF RIVAROXABAN AND PROCESS FOR ITS PREPARATION
- Applicant name
- Krka, tovarna zdravil, d.d.
- Opponent name
- Bayer Intellectual Property GmbH
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 83European Patent Convention R 43(1)
- Keywords
- Sufficiency of disclosure - (no)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.